Literature DB >> 29849081

Clinical experience on diagnosis and treatment for malignancy originating from the dacryocyst.

Li-Juan Zhu1, Yu Zhu2, Shang-Chen Hao1, Pei Huang1, Lin-Lin Wang1, Xiu-Hong Li1, Li-Hong Lian1, Ke Zhang1.   

Abstract

OBJECTIVE: To summarize clinical experience on the diagnosis and treatment for malignancy originating from the dacryocyst.
METHODS: We retrospectively analyzed clinicopathological data from 12 cases that were diagnosed with malignancy originating from the dacryocyst by histopathological examination in our hospital from 2007 to 2017.
RESULTS: Of the 12 cases with malignancy originating from the dacryocyst, 7 were male and 5 were female, with a mean age of 53 years (range, 4-81). Clinical manifestations included a mass in the dacryocyst area in 12 cases, epiphora in 9 cases, pyoid tears in 2 cases, bloody tears in 3 cases, and redness and swelling in the dacryocyst area in 2 cases. Lymphoma occurred in six cases, malignant melanoma in three cases, embryonal rhabdomyosarcoma in one case, and squamous cell carcinoma in two cases.
CONCLUSIONS: Misdiagnosis and missed diagnosis readily occur for malignancy originating from the dacryocyst because its clinical manifestations are diverse. For the suspected patients, it is necessary to perform related examinations. Individualized treatment should be adopted based on pathological types and specific conditions.

Entities:  

Mesh:

Year:  2018        PMID: 29849081      PMCID: PMC6137217          DOI: 10.1038/s41433-018-0132-1

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  19 in total

1.  Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  V Grégoire; J-L Lefebvre; L Licitra; E Felip
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

2.  Malignant lacrimal sac tumors.

Authors:  A Montalban; B Liétin; C Louvrier; M Russier; J-L Kemeny; T Mom; L Gilain
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2010-10-29       Impact factor: 2.080

3.  Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Authors:  R Beverly Raney; David O Walterhouse; Jane L Meza; Richard J Andrassy; John C Breneman; William M Crist; Harold M Maurer; William H Meyer; David M Parham; James R Anderson
Journal:  J Clin Oncol       Date:  2011-02-28       Impact factor: 44.544

Review 4.  Two cases of primary malignant melanoma of the lacrimal sac.

Authors:  H M Lee; H J Kang; G Choi; S W Chae; C H Kim; S J Hwang; S H Lee
Journal:  Head Neck       Date:  2001-09       Impact factor: 3.147

5.  Primary lymphoma of the lacrimal sac: an EORTC ophthalmic oncology task force study.

Authors:  L D Sjö; E Ralfkiaer; B R Juhl; J U Prause; T Kivelä; C Auw-Haedrich; F Bacin; M Carrera; S E Coupland; B Delbosc; N Ducrey; B Kantelip; J L Kemeny; P Meyer; N C Sjö; S Heegaard
Journal:  Br J Ophthalmol       Date:  2006-05-03       Impact factor: 4.638

6.  Long-term course of patients with primary ocular adnexal MALT lymphoma: a large single-institution cohort study.

Authors:  Amrita Desai; Madhura G Joag; Lazaros Lekakis; Jennifer R Chapman; Francisco Vega; Robert Tibshirani; David Tse; Arnold Markoe; Izidore S Lossos
Journal:  Blood       Date:  2016-10-27       Impact factor: 22.113

Review 7.  Tumors of the lacrimal drainage system.

Authors:  Ludwig M Heindl; Anselm G M Jünemann; Friedrich E Kruse; Leonard M Holbach
Journal:  Orbit       Date:  2010-10

Review 8.  Lacrimal sac tumors.

Authors:  M A Stefanyszyn; A A Hidayat; J J Pe'er; J C Flanagan
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1994-09       Impact factor: 1.746

Review 9.  A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma.

Authors:  Maurilio Ponzoni; Silvia Govi; Giada Licata; Silvia Mappa; Antonio Giordano Resti; Letterio S Politi; Lorenzo Spagnuolo; Eliana Di Cairano; Claudio Doglioni; Andrés J M Ferreri
Journal:  Oncologist       Date:  2013-06-28

10.  Ocular adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor.

Authors:  Gerardo F Graue; Paul T Finger; Elizabeth Maher; David Della Rocca; Robert Della Rocca; Gary J Lelli; Tatyana Milman
Journal:  Eur J Ophthalmol       Date:  2013-01-25       Impact factor: 2.597

View more
  2 in total

1.  Blood-stained tears-a red flag for malignancy?

Authors:  Megha Kaushik; Valerie Juniat; Daniel G Ezra; David H Verity; Jimmy Uddin; Hannah Timlin
Journal:  Eye (Lond)       Date:  2022-09-10       Impact factor: 4.456

2.  Immunoglobulin G4-related lacrimal sac dacryocystocele: A novel case report.

Authors:  Sunny Chi Lik Au; Kai Ching Peter Leung; Edwin Chan; Simon Tak Chuen Ko
Journal:  Am J Ophthalmol Case Rep       Date:  2020-06-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.